Clinical trials
Completed Observational Learning Disabilities trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 4 |
| EarliTec Diagnostics, Inc | 2 |
| Indonesia University | 2 |
| Kahramanmaras Sutcu Imam University | 2 |
| SynapDx | 2 |
| University Medical Centre Ljubljana | 2 |
| Acıbadem Atunizade Hospital | 1 |
| Alaska Blind Child Discovery | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Learning Disabilities | 42 |
| Autism Spectrum Disorder | 11 |
| Autistic Disorder | 6 |
| Genetic Diseases, Inborn | 6 |
| Intellectual Disability | 6 |
| Psychomotor Disorders | 4 |
| Attention Deficit Disorder with Hyperactivity | 3 |
| Cerebral Palsy | 3 |
| Developmental Disabilities | 3 |
| Neurodevelopmental Disorders | 3 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.